Quality noteAll products are produced and sold after Crossilico algorithm optimization and experimental validation.

Controls

rAAV-CAG-EGFP-WPRE-hGH polyA

——

Product No.CS-1767
Serotype

AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV8, AAV9, retro, AAV11, AAV13, PHP.eB, BR1, B10, MG1.AAV2, olig001, DJ, php.s, 9/retro, AAV2/PR, AAV2/Ark313, AAV2/PHP.eB, AAV2/DJ, AAV2/MaCPNS2, AAV2/9

Receptor

Not dependent on Cre/Flp —— EGFP

Promoter

CAG Broad-spectrum Promoter

Storage

Store at -80°C

Volume
1E+12GC
1E+12GC>1E+14GC
Titer
≥1E+13GC/mL
≥1E+13GC/mL≥5E+12GC/mL
Selected priceRequest a Quote
Actions

Delivery Information

Usually Ships in 7 Business Days;

Product Details

Promoter Details

CAG, strong promoter, an artificially constructed combined promoter, composed of cytomegalovirus early enhancer and chicken β-actin promoter, 1731bp.

The CAG promoter is a combination of the CMV promoter (C), the chicken β-actin intron (A) and the rabbit β-globin intronic region (G). It is a strong constitutive promoter with no cell tissue specificity;

Functional Gene Details

hChR2(C128S/D156A/T159C): The excitation wavelength is 470nm, no need to implant optical fiber, and light stimulation is applied from outside the skull.

Fluorescent Tag

EGFP

green fluorescent green

Fluorescent Protein Details

EGFP: Green fluorescent protein, excitation wavelength 488nm, emission wavelength 507nm.

Virus Type

Adeno-associated virus vector Adeno-associated Virus

Expression and Regulation Mode

Others

constitutive expression

References and DOI

Bioluminescence-optogenetics-mediated gene therapy in a sleep-disordered breathing mouse model

BMP7 alleviates trigeminal neuralgia by reducing oligodendrocyte apoptosis and demyelination